SCR-LIP-000727 · Claim · machine-readable JSON →

Deleterious variants in genes of lipid metabolism, adipogenesis and insulin signalling are found in a minority of people with lipedema.

General proposition consolidated from 1 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
2 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20222025A Multi-Gene Panel to Identify Lipedema-Predisposing Genetic Variants by a Next-Generation Sequencing Strategy — Michelini et al. (2022) · consistentLipedema: Progress, Challenges, and the Road Ahead — Cifarelli (2025) · contextual

Evidence (2)

Context (PECO)

Populationlipedema patients (n=162)
Conditionlipedema
Exposure305-gene NGS panel sequencing
Outcomeheterozygous deleterious variants in 12 genes
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log